[IgG responses to candidate malaria vaccine antigens in the urban area of Dakar (Senegal): evolution according to age and parasitemia in patients with mild symptoms].

[1]  R. Cibulskis,et al.  World Malaria Report 2013 , 2014 .

[2]  D. Doolan,et al.  Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults , 2011, Malaria Journal.

[3]  A. Oduro,et al.  Antibody levels to multiple malaria vaccine candidate antigens in relation to clinical malaria episodes in children in the Kasena-Nankana district of Northern Ghana , 2011, Malaria Journal.

[4]  O. Garraud,et al.  The use of crude Plasmodium falciparum antigens for comparison of antibody responses in patients with mild malaria vs. cerebral malaria. , 2010, Iranian journal of immunology : IJI.

[5]  Jack S. Richards,et al.  The Relationship between Anti-merozoite Antibodies and Incidence of Plasmodium falciparum Malaria: A Systematic Review and Meta-analysis , 2010, PLoS medicine.

[6]  O. Gaye,et al.  The Quantity and Quality of African Children's IgG Responses to Merozoite Surface Antigens Reflect Protection against Plasmodium falciparum Malaria , 2009, PloS one.

[7]  P. Gilson,et al.  Immunoglobulin G Subclass-Specific Responses against Plasmodium falciparum Merozoite Antigens Are Associated with Control of Parasitemia and Protection from Symptomatic Illness , 2009, Infection and Immunity.

[8]  R. Anders,et al.  Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan. , 2009, Vaccine.

[9]  R. Chilengi,et al.  Humoral Responses to Plasmodium falciparum Blood-Stage Antigens and Association with Incidence of Clinical Malaria in Children Living in an Area of Seasonal Malaria Transmission in Burkina Faso, West Africa , 2007, Infection and Immunity.

[10]  C. Rogier,et al.  Long-Term Clinical Protection from Falciparum Malaria Is Strongly Associated with IgG3 Antibodies to Merozoite Surface Protein 3 , 2007, PLoS medicine.

[11]  N. Byrne Urban malaria risk in sub-Saharan Africa: where is the evidence? , 2007, Travel medicine and infectious disease.

[12]  Morten Hanefeld Dziegiel,et al.  Human Recombinant Antibodies against Plasmodium falciparum Merozoite Surface Protein 3 Cloned from Peripheral Blood Leukocytes of Individuals with Immunity to Malaria Demonstrate Antiparasitic Properties , 2006, Infection and Immunity.

[13]  L. Marrama,et al.  Antibodies to the conserved C-terminal domain of the Plasmodium falciparum merozoite surface protein 1 and to the merozoite extract and their relationship with in vitro inhibitory antibodies and protection against clinical malaria in a Senegalese village. , 2005, Journal of Infectious Diseases.

[14]  P. Atkinson,et al.  Opinion — tropical infectious diseases: Urbanization, malaria transmission and disease burden in Africa , 2005, Nature Reviews Microbiology.

[15]  S. Satpathy,et al.  Severe falciparum malaria , 2004, Indian journal of pediatrics.

[16]  J. Beier,et al.  Malaria transmission in urban sub-Saharan Africa. , 2003, The American journal of tropical medicine and hygiene.

[17]  E. Bourreau,et al.  Evaluation of immunogenicity and protective efficacy of carrier-free Plasmodium falciparum R23 antigen in pre-exposed saimiri sciureus monkeys. , 2000, Vaccine.

[18]  M. Newell Vertical transmission of HIV-1 infection. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[19]  O. Branch,et al.  A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia. , 1998, The American journal of tropical medicine and hygiene.

[20]  C. Rogier,et al.  The Dielmo project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal. , 1994, The American journal of tropical medicine and hygiene.

[21]  A. Tartar,et al.  A novel merozoite surface antigen of Plasmodium falciparum (MSP-3) identified by cellular-antibody cooperative mechanism antigenicity and biological activity of antibodies. , 1994, Memorias do Instituto Oswaldo Cruz.

[22]  G. Langsley,et al.  Plasmodium falciparum: characterization of gene R45 encoding a trophozoite antigen containing a central block of six amino acid repeats. , 1992, Experimental parasitology.

[23]  A. Scherf,et al.  The Pf332 gene codes for a megadalton protein of Plasmodium falciparum asexual blood stages. , 1992, Memorias do Instituto Oswaldo Cruz.

[24]  A. Sabchareon,et al.  Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes , 1990, The Journal of experimental medicine.

[25]  J. Trape,et al.  Malaria and urbanization in central Africa: the example of Brazzaville. Part III: Relationships between urbanization and the intensity of malaria transmission. , 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[26]  I. McGregor,et al.  Gamma-Globulin and Acquired Immunity to Human Malaria , 1961, Nature.